Christian Gratzke
@cgratzke
Urologic Surgeon and Chair, University of Freiburg. Editor-in-Chief, European Urology Focus. Views my own.
ID: 336094461
https://www.uniklinik-freiburg.de/urologie.html 15-07-2011 18:45:02
2,2K Tweet
3,3K Followers
260 Following
Happy to share our mini-review about current evidence on biomarkers for predicting response to enfortumab vedotin for metastatic urinary tract cancer (mUC) Markus Eckstein Eur Urol Focus ➡️ recent literature suggests an overestimation of targetable NECTIN4 expression prevalence
Insights by Michael Leapman on his special issue on the #evironmental impact of healthcare 📉 Significant reduction in carbon emissions and travel distances through telemedicine. 🕒 Saved time and costs across 68M consultations. Severin Rodler Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 doi.org/10.1016/j.euf.…
The #climateemergency in urology. Important issue led by Michael Leapman: 🏥Healthcare sector is a major source of global CO2 emission 🌎 Climate-smart actions as a win-win for patients and the planet. Learn more about the topic: eu-focus.europeanurology.com/issue/S2405-45… Christian Gratzke Severin Rodler
The Department of Urology at Germany’s Uniklinik Freiburg has been treating patients for over 45 years, offering a broad range of diagnosis & treatment to foreign patients. Learn more now! Amer. Urol. Assn. #AUA24 youtu.be/hWKoqq6l5e0
It’s a wrap…#AUA24 Loved seeing everyone ❤️ Looking forward to #AUA25 ♦️♠️❤️♣️ Dave Penson Daniel Lin Christopher J. Kane Sam S. Chang MD, MBA Stacy Loeb, MD Brian F. Chapin Todd 〽️ Morgan, MD Marc Dall'Era Sia Daneshmand, M.D. Christian Gratzke Mark Preston james mckiernan
🔥Prof Christian Gratzke, the Editor-In-Chief interviewed on our two #EBM series published in Eur Urol Focus (>20 articles) Interview available at youtu.be/qk-7cPPoVes?si… More on 1st series: x.com/karitikkinen/s… More on 2nd series: x.com/karitikkinen/s… 📸 Declan Murphy
Final results from SAUL-study🚀: 🌟 14% of patients lived >4 years after treatment. 🔍 16% with grade ≥3 AEs; 8% discontinued due to AEs. 🩺 Broad eligibility criteria included patients with complex comorbidities. Cora Sternberg Axel S. Merseburger Tom Powles doi.org/10.1016/j.euf.…
AI for optimizing prostate cancer literature analysis. 📊 Outperformed PubMed in NHT-NHT sequence relevance 🧬 Similar performance in NHT-PARPi sequence 💡 Better results in NHT/PARPi-177Lu sequence Arnulf Stenzl Andrew Armstrong @asboner Cora Sternberg eu-focus.europeanurology.com/article/S2405-…
On the Road Towards Curing Advanced Bladder Cancer 🆕 EV + pembro as game changer. 💊 Improved Therapies: new IO regimens. 🚀 Future Prospects: new ADCs and biomarkers. Upcoming issue from two superstars in #bladdercancer🤩 eu-focus.europeanurology.com/article/S2405-… Bernadett Szabados and Tom Powles
Out now in European Urology Oncology: Current Treatment Paradigms and Clinical Outcomes in Oligometastatic P... sciencedirect.com/science/articl… Emmanuel Antonarakis
Great to have Tom Powles at #UroTrials in Düsseldorf. Prediction: 80% less cystectomies in the next five years given recent advances in the field. So rCx only in case of local complications/bleeding in the future? Axel S. Merseburger jim catto Benjamin J. Davies MD Alexander Kutikov MD
#ISUO24 International, hochkarätig, hybrid und zweisprachig (Simultan) - Diagnostik, Operative und medikamentöse Therapie aller urologischen Tumore - 24 CMEs- jetzt Plätze sichern isuo.eu/2024/ onkowissen Axel S. Merseburger AUO Christian Gratzke Daniel Eberli aurelius omlin DGU
WoW Wednesday: Re: Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer by Markus Grabbert, Nikolaos Liakos and Christian Gratzke Read it here: europeanurology.com/article/S0302-… #WordsofWisdomWednesday #UroSoMe #MedTwitter #ProstateCancer #PCa